A study looking at personalised treatment for early HER2 positive breast cancer (HER2-RADiCAL)
This study is looking at a personalised treatment plan. It is for people with HER2 positive early breast cancer.
This study is looking at a personalised treatment plan. It is for people with HER2 positive early breast cancer.
This trial is for people who might not be able to have the full dose of treatment because they have other illnesses or are not fit enough.
This study is looking at a test called Cytosponge to see if it can be used to check for cancer of the food pipe (oesophageal cancer) after chemoradiation.
This study is for people with follicular lymphoma who are going to have treatment that reaches their whole body (systemic treatment) for the first time.
This trial is for people who have locally advanced non small cell lung cancer and are having chemotherapy followed by radiotherapy.
This trial is for women with early stage womb cancer who have a high risk of their cancer coming back (recurring) after surgery.
This study looked at 2 operations for people with rectal cancer and compared the side effects.
This trial is for people who have a cancer low down in their bowel (rectum).
Surgery is a treatment for cancer and non cancerous (benign) conditions of the prostate, bladder, penis and kidney.
This study is to collect blood, spit (saliva) and tissue samples to set up a national biobank and database for mantle cell lymphoma.